Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
SPS1-related proline/alanine-rich kinase (SPAK) and oxidative stress-responsive kinase 1 (OSR1) are potent regulators of several transporters and ion channels. The kinases are under regulation of with-no-K(Lys) (WNK) kinases. The present study explored whether SPAK and/or OSR1 modify the expression and/or activity of the voltage-gated K(+) channel Kv1.5, which participates in the regulation of diverse functions including atrial cardiac action potential and tumor cell proliferation. cRNA encoding Kv1.5 was injected into Xenopus oocytes with or without additional injection of cRNA encoding wild-type SPAK, constitutively active (T233E)SPAK, WNK insensitive (T233A)SPAK, catalytically inactive (D212A)SPAK, wild-type OSR1, constitutively active (T185E)OSR1, WNK insensitive (T185A)OSR1, and catalytically inactive (D164A)OSR1. Voltage-gated K(+) channel activity was quantified utilizing dual electrode voltage clamp and Kv1.5 channel protein abundance in the cell membrane utilizing chemiluminescence of Kv1.5 containing an extracellular hemagglutinin epitope (Kv1.5-HA). Kv1.5 activity and Kv1.5-HA protein abundance were significantly decreased by wild-type SPAK and (T233E)SPAK, but not by (T233A)SPAK and (D212A)SPAK. Similarly, Kv1.5 activity and Kv1.5-HA protein abundance were significantly down-regulated by wild-type OSR1 and (T185E)OSR1, but not by (T185A)OSR1 and (D164A)OSR1. Both, SPAK and OSR1 decrease cell membrane Kv1.5 protein abundance and activity.
Achard,
Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
2001, Pubmed
Achard,
Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
2001,
Pubmed
Alesutan,
Upregulation of Na-coupled glucose transporter SGLT1 by Tau tubulin kinase 2.
2012,
Pubmed
,
Xenbase
Almilaji,
Upregulation of Na+,Cl(-)-coupled betaine/γ-amino-butyric acid transporter BGT1 by Tau tubulin kinase 2.
2013,
Pubmed
,
Xenbase
Almilaji,
Down-regulation of Na/K+ atpase activity by human parvovirus B19 capsid protein VP1.
2013,
Pubmed
,
Xenbase
Archer,
Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
2008,
Pubmed
Barfield,
Characterization of potassium channels involved in volume regulation of human spermatozoa.
2005,
Pubmed
Barfield,
The effects of putative K+ channel blockers on volume regulation of murine spermatozoa.
2005,
Pubmed
Bilodeau,
Kv1.5 blockers for the treatment of atrial fibrillation: approaches to optimization of potency and selectivity and translation to in vivo pharmacology.
2009,
Pubmed
Bogatikov,
Up-regulation of amino acid transporter SLC6A19 activity and surface protein abundance by PKB/Akt and PIKfyve.
2012,
Pubmed
,
Xenbase
Bonnet,
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.
2007,
Pubmed
Brendel,
Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
2003,
Pubmed
Capasso,
Channels, carriers, and pumps in the pathogenesis of sodium-sensitive hypertension.
2005,
Pubmed
Castañeda-Bueno,
SPAKling insight into blood pressure regulation.
2010,
Pubmed
Comes,
The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer.
2013,
Pubmed
Delpire,
SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells.
2008,
Pubmed
Delpire,
SPAK and OSR1, key kinases involved in the regulation of chloride transport.
2006,
Pubmed
Falin,
Identification of regulatory phosphorylation sites in a cell volume- and Ste20 kinase-dependent ClC anion channel.
2009,
Pubmed
Falin,
C. elegans STK39/SPAK ortholog-mediated inhibition of ClC anion channel activity is regulated by WNK-independent ERK kinase signaling.
2011,
Pubmed
Felipe,
Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume.
1993,
Pubmed
Felipe,
Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention.
2012,
Pubmed
Flatman,
Cotransporters, WNKs and hypertension: an update.
2008,
Pubmed
,
Xenbase
Furgeson,
Mechanisms of type I and type II pseudohypoaldosteronism.
2010,
Pubmed
Gagnon,
Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.
2012,
Pubmed
Gagnon,
On the substrate recognition and negative regulation of SPAK, a kinase modulating Na+-K+-2Cl- cotransport activity.
2010,
Pubmed
,
Xenbase
Giménez,
Molecular mechanisms and regulation of furosemide-sensitive Na-K-Cl cotransporters.
2006,
Pubmed
Glover,
Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT.
2011,
Pubmed
Glover,
SPAK and WNK kinases: a new target for blood pressure treatment?
2011,
Pubmed
González,
Kv1.5-Kv beta interactions: molecular determinants and pharmacological consequences.
2010,
Pubmed
Henrion,
Overlapping cardiac phenotype associated with a familial mutation in the voltage sensor of the KCNQ1 channel.
2012,
Pubmed
,
Xenbase
Hoffmann,
Physiology of cell volume regulation in vertebrates.
2009,
Pubmed
Hoffmann,
Ion channels involved in cell volume regulation: effects on migration, proliferation, and programmed cell death in non adherent EAT cells and adherent ELA cells.
2011,
Pubmed
Hosseinzadeh,
Upregulation of peptide transporters PEPT1 and PEPT2 by Janus kinase JAK2.
2013,
Pubmed
,
Xenbase
Hosseinzadeh,
Downregulation of ClC-2 by JAK2.
2012,
Pubmed
,
Xenbase
Hosseinzadeh,
Downregulation of KCNQ4 by Janus kinase 2.
2013,
Pubmed
,
Xenbase
Hosseinzadeh,
Down-regulation of the epithelial Na⁺ channel ENaC by Janus kinase 2.
2014,
Pubmed
,
Xenbase
Huang,
Mechanism of regulation of renal ion transport by WNK kinases.
2008,
Pubmed
Kahle,
Phosphoregulation of the Na-K-2Cl and K-Cl cotransporters by the WNK kinases.
2010,
Pubmed
Lang,
Mechanisms and significance of cell volume regulation.
2007,
Pubmed
Leanza,
Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
2014,
Pubmed
Leanza,
Induction of apoptosis in macrophages via Kv1.3 and Kv1.5 potassium channels.
2012,
Pubmed
Lin,
Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
2011,
Pubmed
Mercier-Zuber,
Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
2011,
Pubmed
Mia,
Downregulation of Kv1.5 K channels by the AMP-activated protein kinase.
2012,
Pubmed
,
Xenbase
Miyazaki,
Differential regulation of a CLC anion channel by SPAK kinase ortholog-mediated multisite phosphorylation.
2012,
Pubmed
Munoz,
Up-regulation of the inwardly rectifying K⁺ channel Kir2.1 (KCNJ2) by protein kinase B (PKB/Akt) and PIKfyve.
2013,
Pubmed
,
Xenbase
O'Reilly,
WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.
2003,
Pubmed
Pakladok,
PIKfyve sensitivity of hERG channels.
2013,
Pubmed
,
Xenbase
Pakladok,
Upregulation of the Na⁺-coupled phosphate cotransporters NaPi-IIa and NaPi-IIb by B-RAF.
2014,
Pubmed
,
Xenbase
Park,
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion.
2010,
Pubmed
Pathare,
Enhanced FGF23 serum concentrations and phosphaturia in gene targeted mice expressing WNK-resistant SPAK.
2012,
Pubmed
Pathare,
OSR1-sensitive renal tubular phosphate reabsorption.
2012,
Pubmed
,
Xenbase
Rafiqi,
Role of the WNK-activated SPAK kinase in regulating blood pressure.
2010,
Pubmed
Richardson,
Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways.
2011,
Pubmed
Richardson,
The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway.
2008,
Pubmed
Shojaiefard,
Downregulation of the creatine transporter SLC6A8 by JAK2.
2012,
Pubmed
,
Xenbase
Tamargo,
I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.
2009,
Pubmed
Uchida,
Pathophysiological roles of WNK kinases in the kidney.
2010,
Pubmed
Villa,
Structure of the OSR1 kinase, a hypertension drug target.
2008,
Pubmed
Vitari,
The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
2005,
Pubmed
Vitari,
Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
2006,
Pubmed
Warsi,
Downregulation of chloride channel ClC-2 by Janus kinase 3.
2014,
Pubmed
,
Xenbase
Warsi,
Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2.
2013,
Pubmed
,
Xenbase
Wilson,
Human hypertension caused by mutations in WNK kinases.
2001,
Pubmed
Yang,
SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
2010,
Pubmed
Yeung,
Potassium channels involved in human sperm volume regulation--quantitative studies at the protein and mRNA levels.
2008,
Pubmed
